Rethinking Pharma Supply Chain Resilience In 2021: How Covid-19 Is Accelerating A Critical Digital Transformation

Never before have pharma supply-chain leaders faced more complex, turbulent conditions than during the COVID-19 pandemic. For many, it has been a crash course in crisis management and a stark warning of the need to build resilience against future shocks.

For those in the supply chain, the massive impact on operations has put in sharp relief an industrywide need for change and greater integration of technology for automating workflows and processes.

Throughout 2020, the COVID-19 pandemic has caused global economic turmoil and its repercussions will continue ahead. But if there is one silver lining, it is this: the impact of the global pandemic has exposed the top-to-toe fragility of the pharmaceutical supply chain and the need to turn bottlenecks into growth opportunities.